» Articles » PMID: 36406390

Regulatory Effects of Var. Li. Polysaccharides on Immune System and Gut Microbiota in Cyclophosphamide-induced Mice

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Nov 21
PMID 36406390
Authors
Affiliations
Soon will be listed here.
Abstract

The immuno-regulating potential of edible fungus polysaccharides has gained more and more attention. However, there is little information about the study of var. Li. polysaccharides regulating immunomodulatory activity. The objective of this work to analyze the immunomodulatory activity and the mechanism of var. Li. polysaccharides supplementation in an immunosuppressed mice model induced by cyclophosphamide. The effects of var. Li. polysaccharides on immune system including immune organ indices, immunoglobulin contents, and inflammation cytokines in immunosuppressed mice were determined. In addition, the regulatory effects of var. Li. polysaccharides on the gut microbiota and their metabolites were analyzed. Results showed that var. Li. polysaccharides significantly elevated immune organ indexes, remarkably enhanced the levels of immunoglobulin A (IgA), IgG and IgM in serum and secretory IgA (sIgA) in the intestinal mucosa, conspicuously stimulated the levels of tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2), IL-4, and IL-10 in the serum. var. Li. polysaccharides also could restore gut microbiota to the pattern that is similar with that of the control group with increase of the relative abundances of short-chain fatty acids (SCFAs)-producing bacteria. Furthermore, the content of SCFAs were increased after var. Li. polysaccharides supplementation. This study provides useful information for applications of var. Li. polysaccharides in immune-regulated foods and medicine.

Citing Articles

Effects of Medik polysaccharide derived from different regions on the intestinal immune functions of lambs.

Manafu Z, Du R, Malajiang X, Abulikemu G, Xue L, Bierdelieke A Front Pharmacol. 2024; 15:1422461.

PMID: 39076595 PMC: 11284127. DOI: 10.3389/fphar.2024.1422461.


The Protective Effect of var. Li. Polysaccharide on Alcoholic Liver Disease and Its Effect on Intestinal Microbiota.

Wang T, Jia Z, An C, Ren P, Yang Y, Wang W Molecules. 2023; 28(24).

PMID: 38138493 PMC: 10745760. DOI: 10.3390/molecules28248003.


Modulating the gut microbiota is involved in the effect of low-molecular-weight polysaccharide on immune function.

Song W, Wang Y, Li G, Xue S, Zhang G, Dang Y Gut Microbes. 2023; 15(2):2276814.

PMID: 37948152 PMC: 10653635. DOI: 10.1080/19490976.2023.2276814.


Assessment of var. Li. polysaccharides potential to improve hepatic, antioxidation and intestinal microecology in rats with non-alcoholic fatty liver disease.

Zhou T, Mao X, Jiang W, Pan Y, Chen X, Hu J Front Nutr. 2023; 10:1161537.

PMID: 37377484 PMC: 10292627. DOI: 10.3389/fnut.2023.1161537.

References
1.
Wang X, Lan Y, Zhu Y, Li S, Liu M, Song X . Hepatoprotective effects of Auricularia cornea var. Li. polysaccharides against the alcoholic liver diseases through different metabolic pathways. Sci Rep. 2018; 8(1):7574. PMC: 5953970. DOI: 10.1038/s41598-018-25830-w. View

2.
Zhou Y, Chen X, Yi R, Li G, Sun P, Qian Y . Immunomodulatory Effect of Tremella Polysaccharides against Cyclophosphamide-Induced Immunosuppression in Mice. Molecules. 2018; 23(2). PMC: 6017040. DOI: 10.3390/molecules23020239. View

3.
Cook S, Sellin J . Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998; 12(6):499-507. DOI: 10.1046/j.1365-2036.1998.00337.x. View

4.
Feng S, Liu W, Zuo S, Xie T, Deng H, Zhang Q . Impaired function of the intestinal barrier in a novel sub-health rat model. Mol Med Rep. 2016; 13(4):3459-65. PMC: 4805077. DOI: 10.3892/mmr.2016.4978. View

5.
Park J, Kim M, Kang S, Jannasch A, Cooper B, Patterson J . Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2014; 8(1):80-93. PMC: 4263689. DOI: 10.1038/mi.2014.44. View